In recent years, the pharmaceutical industry has witnessed a surge in the availability of generic medications, often touted as more affordable alternatives to their brand-name counterparts. Jardiance, a medication primarily used to treat type 2 diabetes, is no exception to this trend. With the patent for Jardiance (empagliflozin) expiring, generic versions have started to make […]
Continue Reading